全球氨基糖苷类药物市场 – 行业趋势及 2030 年预测

氨基糖苷类药物市场分析及规模

氨基糖苷类是具有多种治疗危及生命的感染特性的强效抗生素。在人类和动物中，氨基糖苷类在治疗不同细菌感染方面的使用量正在增长，因为它们具有对葡萄球菌和某些分枝杆菌的杀菌活性等特性。在药物领域中，庆大霉素占据了最大的市场份额，预计在预测期内仍将保持主导地位。它用于治疗由细菌引起的严重感染，例如肺部、骨骼、关节、血液、皮肤和泌尿道感染以及脑膜炎。

Data Bridge Market Research 分析了 2023-2030 年预测期内氨基糖苷类药物市场的增长率。在上述预测期内，氨基糖苷类药物市场的预期复合年增长率趋于 4% 左右。2022 年市场价值为 168 万美元，到 2030 年将增长到 230 万美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

氨基糖苷类药物市场范围和细分

Market Definition

Aminoglycosides is the type of medicinal drug classified under bacteriologic gram-negative antibacterial agents and has a major function for restraining protein synthesis. Aminoglycosides consist of a part of the molecule known as amino-adjusted glycoside that is a sugar. It has been used to treat numerous bacterial infections of abdomen and urinary tract, bacteremia and endocarditis and others in humans as well as animals.

Global Aminoglycosides Market Dynamics

Drivers

• Increase in Tuberculosis Cases

The growing burden of tuberculosis is projected to drive the demand for aminoglycosides, particularly in low-income countries where the occurrence is alarmingly high and there is an urgent need for aminoglycosides. For instance, according to WHO 2021 update, a total of 1.5 million people died from tuberculosis in 2020 which includes 214,000 people with HIV. COVID-19 is the second most lethal infectious disease, while tuberculosis is the 13th most common cause of death worldwide.

• Increasing demand for Gentamicin

As per the research article published in 2020 under the title ‘Epidemiology of urological infections: a global burden’, urinary tract infections were among the most frequent infections in clinical practice. The huge burden of urinary tract infections is projected to increase the use of Gentamicin over the forecast period. Gentamicin forms the first line of treatment for several diseases. The usage of Gentamicin is predominantly high in developing regions where it is cost-effective and productive drug for several infectious diseases.

Opportunities

• Rising Adoption Of Injectable and Oral Drugs

Injectable administration is accounted for the largest share. This route is recommended for human medical usage as it provides the optimum mode of drug action mechanism through intravenous or intramuscular route for treatment. Oral use of aminoglycoside antibiotics is generally for bowel surgery to prevent severe infection at the time of surgery. Thus, this feasible route of administration increases the market share.

• Increasing Launch of New Drugs

The rising launch of several new drugs used for the treatment of bacterial infections create opportunities for the market growth. For instance, in November 2020, Huvepharma Inc. launched AVERT NE, a novel new vaccination designed to help manage necrotic enteritis caused by Clostridium perfringens Type A. Curtiss Healthcare, Inc.'s exclusive and proprietary transgenic attenuated Salmonella vaccine (RASV) technology is used as the delivery platform for AvertNE to produce an autoimmune reaction and prevent hens from necrotic enteritis.

 Restraints/Challenges

• Side Effects of Chemotherapy

Several toxic effects associated with these drugs, such as muscle twitching, seizure, and irreversible hearing loss, are responsible for restrictive growth in this industry.

• Long Approval Delays of Drugs

Short provision of quality assured active pharmaceutical ingredient and WHO-GMP compliant product for capreomycin and kanamycin acts as a primary factor which leads in failure of pre-qualification of these drug thus limiting sector growth in more developed countries.

This aminoglycosides market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the aminoglycosides market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Aminoglycosides Market

The COVID-19 outbreak significantly impacted the healthcare sector. According to the article published in 2021 under the title ‘Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents’, aminoglycosides were likely to be used as a base to create powerful COVID-19 medicinal compounds. According to a study published in August 2020 titled ‘Studies highlight the dynamic impact of COVID-19 on antibiotic use’, more than 1,700 hospitalized COVID-19 patients were treated at 38 Michigan hospitals in the U.S. from March 13, 2020, to June 18, 2020, many of them received early antibiotic therapy, with antibiotic use as high as 84% in some hospitals, that showed a positive impact on the market growth. Henceforth, as per the factors mentioned above, COVID-19 significantly impacted the market.

Recent Developments

• In March 2022, Padagis received the U.S. FDA approval for its AB-rated generic version of Tobradex Ophthalmic Suspension. The solution contains active ingredients such as tobramycin and dexamethasone. Tobradex Ophthalmic Suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Global Aminoglycosides Market Scope

The aminoglycosides market is segmented on the basis of drug, application, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Neomycin
• Gentamicin
• Kanamycin
• Other

Application

• Veterinary
• Skin Infection
• Respiratory Diseases
• UTI and Pelvic Diseases
• Other Diseases

Route of Administration

• Injectable
• Topic
• Oral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Aminoglycosides Market Regional Analysis/Insights

The aminoglycosides market is analyzed and market size insights and trends are provided by drug, application, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the aminoglycosides market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for the aminoglycosides market throughout the forecasted period due to increased new research and developments on aminoglycosides markets.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Aminoglycosides Market Share Analysis

氨基糖苷类市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对氨基糖苷类市场的关注有关。

氨基糖苷类药物市场的主要参与者包括：

• Kremoint Pharma Pvt. Ltd.（印度）
• HuvePharma（保加利亚）
• Medison Pharma（印度）
• Medico Remedies Ltd（印度）
• 硕腾 (美国)
• 辉瑞公司 (美国)
• 阿斯利康（英国）
• AbbVie Inc.（美国）
• 梯瓦制药工业公司 (以色列)

SKU-57138